Drug
PF-05175157 clinical trials
Also written PF-05175157.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
11 studies that test it; most in 2012 (3)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PF-05175157 is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult SubjectsCompletedPhase 1PfizerNCT01469468Written as PF-05175157
- A 6-Week Study Of PF-05175157 In Type 2 Diabetes MellitusTerminatedPhase 2PfizerNCT01792635Written as PF-05175157
- Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary ParametersCompletedPhase 1PfizerNCT01819922Written as PF-05175157
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedPhase 2PfizerNCT02053116Written as PF-05175157
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedPhase 2PfizerNCT02053103Written as PF-05175157
- Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne VulgarisWithdrawnPhase 2PfizerNCT02100527Written as PF-05175157
- Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedPhase 1PfizerNCT01807377Written as PF-05175157
- A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet FormulationCompletedPhase 1PfizerNCT01821079Written as PF-05175157
- Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedPhase 1PfizerNCT01757756Written as Pf-05175157
- A Study To Evaluate The Effects Of PF-05175157 In Healthy VolunteersCompletedPhase 1PfizerNCT01537497Written as PF-05175157
- A Study To Evaluate PF-05175157 In Healthy VolunteersCompletedPhase 1PfizerNCT01433380Written as PF-05175157
Codes
What other systems call PF-05175157 · ClinicalTrials.gg INT017555
- Wikidata Q27286356pf-05175157One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27286356 | pf-05175157 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.